广东医学
廣東醫學
엄동의학
GUNAGDONG MEDICAL JOURNAL
2014年
7期
978-981
,共4页
陈子洁%石理%陈曦%姜小飞
陳子潔%石理%陳晞%薑小飛
진자길%석리%진희%강소비
对比剂%急性肾损伤%灯盏花素%Na+,K+-ATP酶
對比劑%急性腎損傷%燈盞花素%Na+,K+-ATP酶
대비제%급성신손상%등잔화소%Na+,K+-ATP매
contrast media%acute kidney injury%Breviscapine%Na+,K+-ATPase
目的:通过观察灯盏花素对对比剂诱导的急性肾损伤大鼠肾脏Na+,K+-ATP酶活性的影响,探讨灯盏花素对对比剂肾损伤大鼠早期的保护作用机制。方法采用健康成年SD大鼠及糖尿病大鼠模型,设正常对照组( NS组)、对比剂对照组( CM组)、灯盏花素治疗组( Bre组)及糖尿病对比剂对照组( DCM组)、糖尿病灯盏花素治疗组( DBre)。 NS组予10 mL/kg生理盐水尾静脉注射,其余各组予等量低渗对比剂。 NS和CM组再予20 mg/( kg· d)腹腔注射、Bre组予等量灯盏花素。一次性腹腔注射链脲佐菌素60 mg/kg建立糖尿病模型,成模糖尿病大鼠注射低渗对比剂后分别予生理盐水及灯盏花素腹腔注射。免疫组化SABC法检测Na+,K+-ATP酶在大鼠肾脏的定位和表达,观察Na+,K+-ATP酶活性变化。结果灯盏花素可使注射对比剂后受抑制的Na+,K+-ATP酶活性表达明显上调(P<0.05),这种作用在糖尿病模型组大鼠(DCM组与DBre组)表现更明显(P<0.01)。结论灯盏花素对大鼠对比剂急性肾损伤有一定的保护作用,该作用可能与减轻对比剂对Na+,K+-ATP酶活性的抑制作用有关。
目的:通過觀察燈盞花素對對比劑誘導的急性腎損傷大鼠腎髒Na+,K+-ATP酶活性的影響,探討燈盞花素對對比劑腎損傷大鼠早期的保護作用機製。方法採用健康成年SD大鼠及糖尿病大鼠模型,設正常對照組( NS組)、對比劑對照組( CM組)、燈盞花素治療組( Bre組)及糖尿病對比劑對照組( DCM組)、糖尿病燈盞花素治療組( DBre)。 NS組予10 mL/kg生理鹽水尾靜脈註射,其餘各組予等量低滲對比劑。 NS和CM組再予20 mg/( kg· d)腹腔註射、Bre組予等量燈盞花素。一次性腹腔註射鏈脲佐菌素60 mg/kg建立糖尿病模型,成模糖尿病大鼠註射低滲對比劑後分彆予生理鹽水及燈盞花素腹腔註射。免疫組化SABC法檢測Na+,K+-ATP酶在大鼠腎髒的定位和錶達,觀察Na+,K+-ATP酶活性變化。結果燈盞花素可使註射對比劑後受抑製的Na+,K+-ATP酶活性錶達明顯上調(P<0.05),這種作用在糖尿病模型組大鼠(DCM組與DBre組)錶現更明顯(P<0.01)。結論燈盞花素對大鼠對比劑急性腎損傷有一定的保護作用,該作用可能與減輕對比劑對Na+,K+-ATP酶活性的抑製作用有關。
목적:통과관찰등잔화소대대비제유도적급성신손상대서신장Na+,K+-ATP매활성적영향,탐토등잔화소대대비제신손상대서조기적보호작용궤제。방법채용건강성년SD대서급당뇨병대서모형,설정상대조조( NS조)、대비제대조조( CM조)、등잔화소치료조( Bre조)급당뇨병대비제대조조( DCM조)、당뇨병등잔화소치료조( DBre)。 NS조여10 mL/kg생리염수미정맥주사,기여각조여등량저삼대비제。 NS화CM조재여20 mg/( kg· d)복강주사、Bre조여등량등잔화소。일차성복강주사련뇨좌균소60 mg/kg건립당뇨병모형,성모당뇨병대서주사저삼대비제후분별여생리염수급등잔화소복강주사。면역조화SABC법검측Na+,K+-ATP매재대서신장적정위화표체,관찰Na+,K+-ATP매활성변화。결과등잔화소가사주사대비제후수억제적Na+,K+-ATP매활성표체명현상조(P<0.05),저충작용재당뇨병모형조대서(DCM조여DBre조)표현경명현(P<0.01)。결론등잔화소대대서대비제급성신손상유일정적보호작용,해작용가능여감경대비제대Na+,K+-ATP매활성적억제작용유관。
Objective To study the effects of Breviscapine on the Na +, K+-ATPase activity in kidney tissues of rats with contrast-induced acute kidney injury .Methods SD rats and diabetic rat models were randomly divided into five groups:normal control group (Group NS), contrast media control group (Group CM), Bre treatment group (Group Bre), diabetic model with contrast media group (Group DCM), and diabetic model with Bre treatment group (Group DBre) .Localization and activity of Na +, K+-ATPase in kidney tissues was detected by immunohistochemistry staining method.Results The activity of Na +, K+-ATPase in kidney tissues, which was inhibited by contrast media , was sig-nificantly enhanced with breviscapine ( P<0.05) , and it was significantly more prominent in diabetic rats ( Group DCM and DBre) (P<0.01).Conclusion Breviscapine provides a certain protection on contrast -induced acute kidney injury in rats, probably via lightening the inhibition of Na +, K+-ATPase activity caused by contrast media .